Monday, April 14, 2008

Fluidigm Files For IPO

South San Francisco-based Fluidigm said in a filing with the SEC today that it is looking to raised up to $86.25M in an IPO on the NASDAQ Global Market. The firm, which develops semiconductors used for gene expression and genotyping work in the life sciences market, said its IPO is being underwritten by Morgan Stanley, UBS Investment Bank, and Leerink Swann. The firm is looking to list as FLDM. Fluidigm is backed by Alloy Funds, EuclidSR, EDB, Fidelity Funds, Interwest, Lheman, SMALLCAP, Versant Ventures, among others.